RxDoctor Payments Data

Javier Nazar

General Practice · Redmond, WANPI 1578359147

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,782 of the $6,607 with a category attached, or 87.5%. Eli Lilly accounts for 80.7% of it on its own, with 2 other manufacturers making up the rest. Among general practice clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,607in general payments, 2019–2025

Across 58 payments — averaging $113.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$5K
  • Novartis$1K
  • Abbott$23
$2,043,272in research payments, 2019–2025

Across 2 payments — averaging $1,021,636 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2M

What the payments were for

  • Travel & lodging$5,78288%
  • Food & beverage$79012%
  • Education$361%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly51$5,334
Novartis6$1,250
Abbott1$23

How this compares

$6,607 in reported general payments places this provider in the 95th percentile of 2,229 general practice providers in Washington.

See all general practice providers in Washington

Other general practice in Redmond

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →